Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$65 | -$29 | -$59 | -$72 |
| Dep. & Amort. | $2 | $2 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $7 | $7 | $4 |
| Change in WC | -$0 | -$28 | -$4 | $33 |
| Other Non-Cash | $1 | $0 | $4 | $19 |
| Operating Cash Flow | -$55 | -$47 | -$51 | -$15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$3 | -$6 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$176 | -$50 | $0 | $0 |
| Inv. Sales/Matur. | $56 | $27 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$120 | -$26 | -$6 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $0 | $0 | $0 |
| Stock Issued | $167 | $0 | $0 | $0 |
| Stock Repurch. | -$4 | -$0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $24 | -$1 | $153 |
| Financing Cash Flow | $162 | $24 | -$1 | $153 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$13 | -$49 | -$58 | $136 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $54 | $103 | $161 | $25 |
| End Cash | $40 | $54 | $103 | $161 |
| Free Cash Flow | -$56 | -$51 | -$57 | -$17 |